文献速递神经肿瘤

无功能垂体腺瘤术后低剂量短效促肾上腺皮质激素试验评估皮质醇反应充足性的截断值

Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma.
PubMed 文献 · Acta Neurochir (Wien) · 2020-01-06

该纵向队列研究纳入117例初次手术的无功能垂体腺瘤患者,术前17%存在继发性肾上腺皮质功能不全,术后3个月降至15%。术后3个月行1μg短效促肾上腺皮质激素试验,峰值皮质醇≥320 nmol/l(11.6 μg/dl)提示反应充足,<309 nmol/l(11.2 μg/dl)提示继发性肾上腺皮质功能不全。

要点

  • 无功能垂体腺瘤术后新发继发性肾上腺皮质功能不全罕见,经蝶手术安全。
  • 仅靠晨间皮质醇诊断继发性肾上腺皮质功能不全会出现假阳性,短效促肾上腺皮质激素试验仍有价值。
  • 术后3个月短效促肾上腺皮质激素试验峰值皮质醇≥320 nmol/l(11.6 μg/dl)提示反应充足。

核心结论

  • 垂体手术安全,经蝶手术很少导致新发继发性肾上腺皮质功能不全;仅靠晨间皮质醇诊断继发性肾上腺皮质功能不全会出现假阳性,短效促肾上腺皮质激素试验仍有价值;短效促肾上腺皮质激素试验峰值皮质醇≥320 nmol/l(11.6 μg/dl)提示反应充足,<309 nmol/l(11.2 μg/dl)提示继发性肾上腺皮质功能不全。

研究设计与样本

  • 纵向队列研究,纳入117例(女性52例/男性65例,年龄59岁)因临床无功能垂体腺瘤行初次手术的患者,术前晨间血样测皮质醇,术后3个月行短效促肾上腺皮质激素试验。

主要发现

  • 所有肿瘤均为大腺瘤(平均大小26.9 mm,范围13-61 mm)。
  • 手术指征为视力损害(93例)、肿瘤生长(16例)、垂体卒中(6例)和头痛(2例)。
  • 术前17%的患者存在继发性肾上腺皮质功能不全,术后3个月降至15%。
  • 因垂体卒中手术的患者继发性肾上腺皮质功能不全风险增加(p < 0.001),而年龄、性别、肿瘤大小和并发症发生率与其余队列无差异。
  • 术后3个月,所有基线皮质醇≥172 nmol/l(6.2 μg/dl)且短效促肾上腺皮质激素试验峰值皮质醇≥320 nmol/l(11.6 μg/dl)的患者顺利递减可的松。

关键数值与推荐

  • 术后3个月短效促肾上腺皮质激素试验峰值皮质醇≥320 nmol/l(11.6 μg/dl)提示反应充足。
  • 短效促肾上腺皮质激素试验峰值皮质醇<309 nmol/l(11.2 μg/dl)提示继发性肾上腺皮质功能不全。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim was to study the prevalence of secondary adrenal insufficiency before and after surgery for non-functioning pituitary adenomas, as well as determine risk factors for developing secondary adrenal insufficiency. A secondary aim was to determine adequate p-cortisol response to a 1-μg Short Synacthen Test after surgery. DESIGN: Longitudinal cohort study. METHODS: One hundred seventeen patients (52/65 females/males, age 59 years) undergoing primary surgery for clinically non-functioning pituitary adenomas were included. P-cortisol was measured in morning blood samples. Three months after surgery, a Short Synacthen Test was performed. RESULTS: All tumours were macroadenomas (mean size 26.9 mm, range 13-61 mm). The surgical indications were visual impairment (93), tumour growth (16), pituitary apoplexy (6) and headache (2). Before surgery, 17% of the patients had secondary adrenal insufficiency (SAI), decreasing to 15% 3 months postoperatively. Risk of SAI was increased in patients operated for pituitary apoplexy (p < 0.001), while age, sex, tumour size and complication rate were not different from the remaining cohort. Three months after surgery, all patients with baseline p-cortisol ≥ 172 nmol/l (6.2 μg/dl) and peak p-cortisol during Short Synacthen Test ≥ 320 nmol/l (11.6 μg/dl) tapered cortisone unproblematically. In patients with intact hypothalamic-pituitary-adrenal axis, p-cortisol peaked < 500 nmol/l (18.1 μg/dl) during Short Synacthen Test in 48% of patient. CONCLUSION: Pituitary surgery is safe and transsphenoidal surgery rarely causes new SAI. Relying solely on morning p-cortisol for diagnosing secondary adrenal insufficiency gives false positives and the Short Synacthen Test remains useful. A peak p-cortisol ≥ 320 during (11.6 μg/dl) Short Synacthen Test indicates a sufficient response, while < 309 nmol/l (11.2 μg/dl) indicates secondary adrenal insufficiency.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Kolnes AJ, Øystese KA, Dahlberg D, et al. Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma. Acta Neurochir (Wien). 2020. PMID: 31907611. doi:10.1007/s00701-019-04068-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。